Skip to main content

Top Left Menu

  • Careers
  • Media
  • Investors
  • Library

What are you looking for?

Home

You are here

Galderma Global

Choose another location

  • Argentina
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Hong Kong/Macau SAR, China
  • India
  • Italy
  • Japan
  • Kingdom of Saudi Arabia
  • Korea
  • Mainland China
  • Mexico
  • Middle East
  • Netherlands
  • Nordic
  • Norway
  • Poland
  • Portugal
  • Russia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Taiwan, China
  • Thailand
  • United Kingdom
  • United States
  • Venezuela

Top menu

  • Contact us
  • Search

Main navigation

  • About us
    • At a glance
    • Our purpose
    • Our strategy
    • Our sub-categories
    • Global presence
    • Executive Committee
    • Governance
    • Annual Report 2025
  • Skin Stories
    • Galderma skin stories
    • Skin Science
    • Beauty x Medicine
    • Galderma Insights
    • Podcasts
  • Innovation
    • Bringing innovation to life
    • Partnerships
    • Manufacturing
    • Early Access
  • Our brands
  • Sustainability
    • For our employees
    • For patients and consumers
    • For healthcare professionals and customers
    • Governance oversight
    • Funding request for education and support activities
    • Our ESG Index
  • Media
  • Careers
  • Investors
You searched for: «【✈️ Telegram ID: KPU77】 대성피 성인 피시방 안전 보장 100% 알거래 중개소 리스트 - 용인»
Results 101 - 105 of 155
Page 21 of 31
  1. Media
  2. Newsroom

Cetaphil® Launches Innovative Digital Campaign to Connect with Millions of Consumers Experiencing Skin Sensitivity

Cetaphil on a mission to help the 70% of Americans that self-diagnose as having sensitive skin1 with first-hand access to experts and science-driven recommendations.

 

  1. Media
  2. Newsroom

Cetaphil® Unveils Premium Product Line with New HydroSensitiv™ Complex That Delivers 48-Hour Hydration

The #1 Dermatologist-Recommended Facial Skincare Brand Introduces Six New Product Launches, Specifically Formulated for Dry, Sensitive Skin

 

  1. Media
  2. Newsroom

Galderma receives approval for Restylane® Vital™, Restylane® Lyft™, and Restylane® Lidocaine in China

  • First approval for a class III medical device for improved skin appearance in China
  • First introduction of the new product category “Skinboosters” in China

 

  1. Media
  2. Newsroom

A Decade of Dysport®: Galderma Celebrates 10 Years Since FDA Approval of Dysport in the U.S.

Spotlighting the long-term safety and efficacy profile of Dysport for aesthetic use and the natural results yielding high patient satisfaction

 

  1. Media
  2. Newsroom

Galderma continues global growth ambition with Sculptra® (injectable poly-L-lactic acid) re-launch in Europe

  • Updated administration protocol means Sculptra® offers the fastest reconstitution of any injectable poly-L-lactic acid (PLLA) available in Europe
  • Updated protocol allows for faster and more convenient administration of Sculptra® with the optional addition of lidocaine to increase patient comfort
  • Update i
Results 101 - 105 of 155
Page 21 of 31

Pagination

  • Previous page Previous Page
  • Next page Next Page
  1. Home
  2. Search results

STAY CONNECTED

Follow us on Social Media for current news and patients stories

Instagram LinkedIn Icon Twitter Icon
© Galderma 2026

Footer menu 2

  • Terms of use
  • Cookie Policy
  • Privacy
  • Sitemap

Confirm navigation

You are about to leave the Galderma global site. Are you sure you want to leave this page?

Yes, thanks Go back